Study of Self or Clinic Administration of DepoProvera

Completed · Not applicable

Conditions studied: Contraception

In brief

Depot medroxyprogesterone acetate (DepoProvera) is an acceptable form of contraception for many women. However, difficulty in access may cause many women to discontinue use, often without the use of another effective method of contraception, thereby leaving them vulnerable to unintended pregnancy. This study will randomly assign women who present for contraceptive services to two groups: self or clinic administered SC DMPA. The participants will be followed for one year to compare continuation rates, acceptability, cost effectiveness, evidence of skin changes, and need for continued support between the two groups.

Key facts

Study ID

NCT01019369

Run by

Carolyn L. Westhoff

People needed

132

Starts

2010-03-01

Expected to finish

2012-11-01

Last updated by the study team

2019-05-07

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• age greater than or equal to 18 years
• seeking DMPA for contraception
• English or Spanish speaking
• consistent access to a working telephone
• availability for follow up for one year

You may not qualify if…

• suspected or continuing pregnancy
• undiagnosed vaginal bleeding
• known or suspected breast cancer
• acute liver disease
• known hypersensitivity to medroxyprogesterone acetate or any other components of DMPA
• desire for pregnancy within one year

Where it is running

• Columbia University/New York Presbyterian Hospital — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.